41. BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists.
作者: K Chakravarty.;H McDonald.;T Pullar.;A Taggart.;R Chalmers.;S Oliver.;J Mooney.;M Somerville.;A Bosworth.;T Kennedy.; .; .
来源: Rheumatology (Oxford). 2008年47卷6期924-5页 42. British Society for Rheumatology and british health professionals in Rheumatology guideline for the management of rheumatoid arthritis (the first two years).
作者: R Luqmani.;S Hennell.;C Estrach.;F Birrell.;A Bosworth.;G Davenport.;C Fokke.;N Goodson.;P Jeffreson.;E Lamb.;R Mohammed.;S Oliver.;Z Stableford.;D Walsh.;C Washbrook.;F Webb.; .; .
来源: Rheumatology (Oxford). 2006年45卷9期1167-9页 43. BSR & BHPR, BOA, RCGP and BSAC guidelines for management of the hot swollen joint in adults.
作者: G Coakley.;C Mathews.;M Field.;A Jones.;G Kingsley.;D Walker.;M Phillips.;C Bradish.;A McLachlan.;R Mohammed.;V Weston.; .
来源: Rheumatology (Oxford). 2006年45卷8期1039-41页 44. BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology.
作者: A Keat.;N Barkham.;A Bhalla.;K Gaffney.;H Marzo-Ortega.;S Paul.;F Rogers.;M Somerville.;R Sturrock.;P Wordsworth.; .
来源: Rheumatology (Oxford). 2005年44卷7期939-47页 47. Update on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001).48. Immunization in rheumatic diseases of childhood: an audit of the clinical practice of British Paediatric Rheumatology Group members and a review of the evidence.
To establish opinion and clinical practice of senior clinicians working with children with rheumatic diseases with regard to immunization and to determine whether or not this is in accordance with current recommendations. To review published guidelines on the subject and examine the evidence base supporting them.
|